Image de couverture de livre

Clinical characteristics and complication risks in data‐driven clusters among Chinese community diabetes populations

Fuente: Wiley Open Access

Enregistré dans:

Détails bibliographiques
Auteurs principaux:	Binqi Li, Zizhong Yang, Yang Liu, Xin Zhou, Weiqing Wang, Zhengnan Gao, Li Yan, Guijun Qin, Xulei Tang, Qin Wan, Lulu Chen, Zuojie Luo, Guang Ning, Weijun Gu, Yiming Mu
Format:	Artículo Open Access
Publié:	Wiley 2024
Sujets:	Journal of Diabetes
Accès en ligne:	Acceder al recurso
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

Remnant cholesterol is more positively related to diabetes, prediabetes, and insulin resistance than conventional lipid parameters and lipid ratios: A multicenter, large sample survey
par: Binqi Li, et autres
Publié: (2024)

Remnant cholesterol, but not other traditional lipids or lipid ratios, is independently and positively related to future diabetes risk in Chinese general population: A 3 year cohort study
par: Binqi Li, et autres
Publié: (2024)

Development and validation of a machine learning‐based model to predict isolated post‐challenge hyperglycemia in middle‐aged and elder adults: Analysis from a multicentric study
par: Rui Hou, et autres
Publié: (2024)

Association of body roundness index with cardiovascular disease and all‐cause mortality among Chinese adults
par: Hong Lin, et autres
Publié: (2025)

Association between weight‐adjusted‐waist index and incident carotid atherosclerosis in the general adult population in Chinese communities: Evidence from the REACTION cohort study
par: Qingzheng Wu, et autres
Publié: (2025)

Association of advanced glycation end products with ear lobe crease: A cross‐sectional study
par: Yuepeng Wang, et autres
Publié: (2024)

Efficacy and safety of iGlarLixi versus IDegAsp by baseline β‐cell function in Chinese people with type 2 diabetes: Exploratory analyses of the Soli‐D study
par: Weijun Gu, et autres
Publié: (2025)

The causal relationship between plasma protein‐to‐protein ratios and type 2 diabetes and its complications: Proteomics mendelian randomization study
par: Yue‐Yang Zhang, et autres
Publié: (2024)

Association Between Socioeconomic Status and the Prevalence of Metabolic Diseases: A Nationwide Cross‐Sectional Study in China
par: Minghan Zhang, et autres
Publié: (2026)

Body size, insulin sensitivity, metabolic health and risk of cardiovascular disease in Chinese adults: Insights from the China Cardiometabolic Disease and Cancer Cohort (4C) study
par: Chunyan Hu, et autres
Publié: (2024)

The efficacy and safety of iGlarLixi versus IDegAsp in Chinese people with type 2 diabetes suboptimally controlled with oral antidiabetic drugs: The Soli‐D randomized controlled trial
par: Ming Liu, et autres
Publié: (2024)

Identification of subtypes of type 2 diabetes in the Chinese population and their distinct complication risk profiles
par: Qiu Xiao, et autres
Publié: (2025)

The efficacy and safety of insulin glargine 100 U/mL + lixisenatide versus insulin degludec + insulin aspart in Chinese people with type 2 diabetes suboptimally controlled with oral antidiabetic drugs: The Soli‐D randomized controlled trial
par: Yiming Mu
Publié: (2024)

Front Cover
par: Hong Lin, et autres
Publié: (2025)

Front Cover
par: Chunyan Hu, et autres
Publié: (2024)

Protective effects of 23‐valent pneumococcal polysaccharide vaccination against mortality among elder patients with type 2 diabetes mellitus
par: Xiaoling Peng, et autres
Publié: (2026)

Development and validation of a prediction model for self‐reported hypoglycemia risk in patients with type 2 diabetes: A longitudinal cohort study
par: Hongmei Xu, et autres
Publié: (2024)

The role of vascular adhesion protein‐1 in diabetes and diabetic complications
par: I‐Weng Yen, et autres
Publié: (2024)

Effects of SGLT2 inhibitors on development and progression of kidney disease in Chinese patients with type 2 diabetes: A multicentre, prospective real‐world study
par: Yun Wang, et autres
Publié: (2025)

Pathophysiology of type 2 diabetes: A focus on the metabolic differences among southeast Asian, Chinese and Indian populations and how this impacts treatment
par: Yuzi Cao, et autres
Publié: (2025)

Clinical metabolomics characteristics of diabetic kidney disease: A meta‐analysis of 1875 cases with diabetic kidney disease and 4503 controls
par: Yu Yuan, et autres
Publié: (2024)

Cofrogliptin once every 2 weeks as add‐on therapy to metformin versus daily linagliptin in patients with type 2 diabetes in China: A randomized, double‐blind, non‐inferiority trial
par: Qian Ren, et autres
Publié: (2024)

Trajectories of body mass index and diabetes mellitus risk among elderly Chinese adults: A 10‐year longitudinal study
par: Yan Guo, et autres
Publié: (2025)

Comparison of ultrasound scanning and clinical examination for detecting insulin injection related Lipohypertrophy and construction of Lipohypertrophy classification table
par: Hongmei Xu, et autres
Publié: (2024)

Evaluating the incidence of complications among people with diabetes according to age of onset: Findings from the UK Biobank
par: Seyedeh Forough Sajjadi, et autres
Publié: (2024)

Association Between Skin Autofluorescence and Coronary Heart Disease in Chinese General Population: A Cross‐Sectional Study
par: Qingzheng Wu, et autres
Publié: (2025)

Early Glycemic Control With iGlarLixi Versus IDegAsp in Chinese Adults With Type 2 Diabetes: A Post Hoc Analysis of the Soli‐D Study
par: Xiaohong Wu, et autres
Publié: (2025)

The exosome‐ PI3K /Akt‐autophagy axis in diabetic vascular complications: Mechanisms and implications
par: Wei Liu, et autres
Publié: (2025)

Effectiveness of finerenone in Chinese patients with type 2 diabetes mellitus and chronic kidney disease with microalbuminuria: A retrospective real‐world study
par: Yiming Wu, et autres
Publié: (2025)

Real‐world glycaemic outcomes of automated insulin delivery in type 1 diabetes: A meta‐analysis
par: Qin Yang, et autres
Publié: (2024)

Amino acid metabolism modulates chronic kidney disease progression by mediating the aging process: Mechanistic insights and therapeutic interventions
par: Yi Song, et autres
Publié: (2026)

Real‐world treatment satisfaction with dulaglutide, and its influencing factors, in a Chinese population with type 2 diabetes mellitus
par: Lixin Guo, et autres
Publié: (2024)

Gestational diabetes risk associated with early pregnancy blood pressure characteristics and trajectories: A Chinese prospective cohort study
par: Weigui Ni, et autres
Publié: (2025)

Associations of body mass index trajectory, waist circumference trajectory, or both with type 2 diabetes mellitus risk in Chinese adults: The China‐PAR project
par: Yang Zhao, et autres
Publié: (2024)

Association between two novel anthropometric measures and type 2 diabetes in a Chinese population
par: Di Wang, et autres
Publié: (2024)

Visit‐to‐visit HbA1c variability, risk of all‐cause mortality and diabetes‐related vascular complications among adult individuals with type 2 diabetes mellitus
par: Moses Yidong Lim, et autres
Publié: (2026)

Anthropometric metabolic subtypes and health outcomes: A data‐driven cluster analysis
par: Li Ding, et autres
Publié: (2025)

Diagnosis and treatment of diabetic foot ulcer complicated with lower extremity vasculopathy: Consensus recommendation from the Chinese Medical Association (CMA), Chinese Medical Doctor Association (CMDA)
par: Kejia Wang, et autres
Publié: (2024)

The interaction effect between BMI , diabetes and age at diabetes onset on the risk of thyroid cancer: A population‐based cohort study in Shanghai, China
par: Tianzhichao Hou, et autres
Publié: (2024)

Safety and efficacy of hybrid closed‐loop insulin pump therapy in adolescents and adults with type 1 diabetes in China
par: Jing Shen, et autres
Publié: (2025)